China SFDA Official Expects H1N1 Vaccine Shots To Ready In July
This article was originally published in PharmAsia News
Chinese authorities expect to have a vaccine against the A/H1N1 flu virus ready for inoculations by the end of July. They are counting on receipt of the strain in early June from the World Health Organization directly to drug makers, who are required to produce one following strict WHO protocols. The WHO had said slower-than-usual growth of the virus in laboratories meant the strain would not be available earlier than mid-July. The head of the State FDA's biology-production department said 11 drug companies are capable of producing seasonal flu vaccines, but only one can make the pandemic vaccine. (Click here for more
You may also be interested in...
AdvaMed’s VentConnect platform is expanding to support production of devices needed to treat COVID-19. Here’s what Eric Fanning, CEO of participating group the Aerospace Industries Association, said about the move.
Preliminary plans for an Oct. 22 meeting of US FDA's vaccine advisory committee suggest a fast evaluation of COVID-19 immunizations, bringing mixed reactions from onlookers who say it could be a positive sign of needed public transparency or an indication the agency is rushing to approve a product ahead of the November presidential election.
Lawyer asks US FDA to require another trial before licensing Mesoblast’s stem cell therapy for children with SR-aGVHD; Incyte’s Jakafi is only product approved for the indication.